Research Article

Residual Dyslipidemia Leads to Unfavorable Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention

Table 1

Patient characteristics, risk categories, and lipid parameters.

All patientsLDL-C
at goal
LDL-C
not at goal
Normal HDL-CLow HDL-CNormal TGHigh TG

304743126161127192017421305
Age (years)59.6 ± 10.659.8 ± 10.559.6 ± 10.760.6 ± 10.459.1 ± 10.7##60.8 ± 10.558.1 ± 10.6††
Female (%)23.017.424.016.526.9##22.723.5
BMI (kg/m2)25.8 ± 3.125.5 ± 3.125.9 ± 3.125.3 ± 3.026.1 ± 3.125.4 ± 3.126.3 ± 3.0††
SBP (mmHg)128.7 ± 19.3128.5 ± 19.6128.7 ± 19.2129.7 ± 19.1128.1 ± 19.3#128.8 ± 19.9128.6 ± 18.3
DBP (mmHg)78.3 ± 10.978.1 ± 10.678.4 ± 11.078.6 ± 11.078.2 ± 10.977.9 ± 10.979.0 ± 11.0††
TC (mg/dL)175.4 ± 43.8128.7 ± 22.7183.2 ± 41.5189.6 ± 45.5167.4 ± 40.6##166.3 ± 39.3187.9 ± 46.4††
HDL-C (mg/dL)39.6 ± 9.236.2 ± 8.640.2 ± 9.248.2 ± 8.334.9 ± 5.5##40.6 ± 9.138.3 ± 9.1††
LDL-C (mg/dL)104.6 ± 34.860.5 ± 8.4112.1 ± 32.0111.5 ± 37.7100.8 ± 32.5##101.6 ± 33.8108.7 ± 35.8††
TG (mg/dL)137 (100–191)121 (85–176)140 (103–193)123 (90–171)145 (107–201)##105 (84–126)204 (172–259)††
FBG (mg/dL)109.9 ± 39.1109.7 ± 42.2109.9 ± 38.5107.3 ± 35.1111.4 ± 41.1##106.1 ± 36.7115.2 ± 41.5††
eGFR (mL/min)85.7 ± 25.688.4 ± 31.185.2 ± 24.785.6 ± 25.685.7 ± 25.886.6 ± 26.184.4 ± 25.2
LVEF (%)58.3 ± 10.958.1 ± 10.658.4 ± 11.058.6 ± 11.058.2 ± 10.957.9 ± 10.959.0 ± 11.0
Current smoker (%)34.129.534.934.134.133.535.0
Hypertension (%)61.864.561.458.663.8##60.463.8
Diabetes mellitus (%)26.630.226.022.528.9##22.731.7††
Multivessel disease (%)46.746.246.743.744.146.947.0

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; FBG: fasting blood glucose; eGFR: estimated glomerular filtration rate; LVEF: left ventricular ejection fraction. , compared with LDL-C at goal group; #, ## compared with normal HDL-C group; , †† compared with normal TG group.